DEBRA GOLDMAN: Open Payments
NPI 1457904252 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,710 in 130 payments from 28 companies in 2025. Trend: 2023 $839 · 2024 $1,635 · 2025 $2,710
Food & beverage: $2,710
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $452 |
| ABBVIE INC. | 19 | $434 |
| Lilly USA, LLC | 14 | $338 |
| Amgen Inc. | 22 | $266 |
| Novo Nordisk Inc | 10 | $139 |
| PFIZER INC. | 5 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Astellas Pharma US Inc | 3 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
Products named: AIRSUPRA, EVENITY, CREON, UBRELVY, JARDIANCE, MOUNJARO, CAPLYTA, OTEZLA.
Industry payments across AZ — which companies pay providers there.
